We are working with early psychosis research teams to develop research proposals and apply for funding for two exciting new clinical trials:
Empowering Choice
A clinical trial of shared decision-making about medication to support recovery from first-episode psychosis.
“Many people who are prescribed anti-psychotic medications are provided with limited information about their options and even less about how to manage side effects. Our study wants to determine whether empowering people to make decisions about their medication alongside their psychiatrist has a positive impact on their long-term outcomes.” Professor Kelly Allott, Principal Investigator
Applications to join the Empowering Choice advisory group have now closed. Thanks to all the applicants, we will be in touch with you shortly.
Bridging the gap
Implementation of exercise in early intervention services to improve long-term outcomes.
“The benefits of exercise on reducing psychosis symptoms are clear. However, exercise-related treatments are not always available in early intervention services and are often not appealing to young people. We want to test how implementing evidence-based exercise interventions that prioritise participant choice will deliver improved quality of life over the long term.” Professor Stephen Wood, Principal Investigator
These trials have been developed under the psychosis sector research priority: ‘What treatments deliver the best long-term outcomes for people with early psychosis?’
AEPCC established the research priority following extensive consultation with researchers, clinicians and the lived experience community last year. We then invited Australian psychosis researchers to submit an expression of interest (EOI) to conduct a trial under this priority with AEPCC support.
If you would like to get in touch with the principal investigators, please email:
